期刊文献+

心血管标志物POCT院内质量管理实践 被引量:7

In-hospital Management of POCT for Cardiovascular Biomarkers
下载PDF
导出
摘要 目的心脏标志物point-of-care testing(POCT)检测因其快速、便捷的特点已经成为急重症临床科室的需求对象。本文介绍了阜外医院在规范化管理心脏标志物POCT实践中的积极探索以及遇到的问题。方法对实施规范化管理后3个月的室内质控数据进行统计分析。结果院内心脏标志POCT检测的室内质控100%开展,两个品牌共11台仪器中cardiac troponin I(c Tn I)、N-terminal prohormone of brain natriuretic peptide(NT-pro BNP)和D-二聚体的室内质控总不精密度和偏倚达到预期的质量管理目标。一致性比较显示两个品牌检测c Tn I和NT-pro BNP的结果与中心实验室的结果相关性良好,而D-二聚体的检测结果也具有一定可比性。结论证实通过探索和努力建立了切实可行的心脏标志物POCT院内管理体系,该体系能够保证POCT检测的稳定性和质量。 Objective The Point- of- care testing (POCT) for cardiovascular biomarkers is universally employed by emergency department due to the advantage of simple operation and rapid results. We introduced here the Fuwai hospital practice in in-hospital management of POCT for cardiovascular biomarkers. Methods After the standardized management of POCT was performed for three consecutive months, the data of internal quality control were collected and analyzed. Results The standardized internal quality control were implemented in all clinical units. The total imprecision and bias of Cardiac troponin I ( cTnI), N- terminal prohormone of brain natriuretic peptide ( NT- proBNP) and D- dimerfrom from 11 POCT devices of two brands met our aim of POCT quality control. The two POCT for cTnI and NT-proBNP showed good correlations with auto-analyzer from clinical laboratory. For D-dimer analyst the moderate correlation was observed. Conclusion Fuwai's in-hospital management of POCT for Cardiovascular biomarkers is practical and efficient to guarantee the stability and quality of POCT.
出处 《标记免疫分析与临床》 CAS 2018年第1期133-137,共5页 Labeled Immunoassays and Clinical Medicine
基金 国家国际科技合作专项(2014DFG32540) 协和青年基金(编号:3332015107)
关键词 心血管标志物 POCT 质量管理 Cardiovascular biomarkers POCT Quality management
  • 相关文献

参考文献3

二级参考文献84

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2121
  • 2Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J, 1995,9:755-767.
  • 3Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol, 1991,67 : 1360-1367.
  • 4Morrow DA, Cannon CP, Jesse RL, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clinical Chemistry, 2007,53 : 552- 574.
  • 5Vasile VC, Saenger AK, Kroning JM, et al. Biological and analytical variability of a novel high-sensitivitycardiac troponin T assay. Clin Chem, 2010,56 : 1086-1090.
  • 6Apple FS, Collinson PO, IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem, 2012,58:54-61.
  • 7Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J, 2011,162:81-88.
  • 8Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med, 2009,361:868-877.
  • 9Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med,2009,361:858-867.
  • 10Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem, 2010,56:642-650.

共引文献1531

同被引文献50

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部